FDA Recalls For Dec. 25, 2013
This article was originally published in The Tan Sheet
Executive Summary
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
You may also be interested in...
Litigation Follows OTC Eye Drops Recall Due To Bacteria Strain Not Previously Seen In US
Following a recall earlier in February of EzriCare’s and Delsam’s OTC artificial tears due to potential bacterial contamination, plaintiffs’ bar steps in with first of what may be multiple lawsuits. CDC says drug-resistant strain of Pseudomonas aeruginosa bacteria not previously seen in US.
Sterility Concerns Spark Altaire's CVS, Walmart, Walgreens Eye Drop Recalls
Altaire "is initiating the recall due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility," firm says in its recall announcements.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.